Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other ...

Long-term weight stability is recommended to improve health outcomes in individuals with type 1 diabetes. Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling ...

Losing and regaining weight repeatedly—a pattern known as yo-yo dieting or body-weight cycling—can significantly increase the risk of kidney disease in people with type 1 diabetes ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes ... 1 drug tirzepatide is over Folks who took one of ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...